How Does Becton Dickinson Make its Money?
Becton, Dickinson and Company (BD) is a global medical technology company and one of the world’s largest manufacturers of medical supplies, devices, laboratory instruments, and diagnostic products. The company is best known for its syringes, needles, and blood collection systems — products used billions of times each year in hospitals, labs, and clinics worldwide. BD also provides medication management systems, infection prevention products, and diagnostic instruments. The company has been undergoing a planned separation to spin off its Biosciences segment into a standalone company to sharpen focus.
Becton Dickinson (BDX) Business Model
Becton Dickinson operates in the medical devices sector. Below is a summary of Becton Dickinson’s revenue streams, how the company generates income, and the key financial metrics from its most recent annual report. This breakdown uses data from Becton Dickinson’s 2024 fiscal year filings with the SEC.
Becton Dickinson Competitors
Becton Dickinson’s key competitors and comparable public companies in the medical devices sector include Abbott Laboratories, Stryker, Medtronic, and Boston Scientific. Each of these companies competes for market share, investor attention, and revenue in overlapping segments. See how Becton Dickinson stacks up by comparing their revenue breakdown, margins, and growth metrics.
Becton Dickinson Competitors
Becton Dickinson’s key competitors and comparable public companies in the medical devices sector include Abbott Laboratories, Stryker, Medtronic, and Boston Scientific. Each of these companies competes for market share, investor attention, and revenue in overlapping segments. See how Becton Dickinson stacks up by comparing their revenue breakdown, margins, and growth metrics.
Becton Dickinson Competitors
Becton Dickinson’s key competitors and comparable public companies in the medical devices sector include Abbott Laboratories, Stryker, Medtronic, and Boston Scientific. Each of these companies competes for market share, investor attention, and revenue in overlapping segments. See how Becton Dickinson stacks up by comparing their revenue breakdown, margins, and growth metrics.
Becton Dickinson Competitors
Becton Dickinson’s key competitors and comparable public companies in the medical devices sector include Abbott Laboratories, Stryker, Medtronic, and Boston Scientific. Each of these companies competes for market share, investor attention, and revenue in overlapping segments. See how Becton Dickinson stacks up by comparing their revenue breakdown, margins, and growth metrics.
Becton Dickinson Competitors
Becton Dickinson’s key competitors and comparable public companies in the medical devices sector include Abbott Laboratories, Stryker, Medtronic, and Boston Scientific. Each of these companies competes for market share, investor attention, and revenue in overlapping segments. See how Becton Dickinson stacks up by comparing their revenue breakdown, margins, and growth metrics.
Revenue Breakdown
| Segment | 2024 | 2023 | YoY Growth |
|---|---|---|---|
| BD Medical (Medication Delivery, Medication Management, Pharm Systems) | $10,100 | $9,700 | +4.1% |
| BD Life Sciences (Biosciences, Diagnostics) | $5,900 | $5,700 | +3.5% |
| BD Interventional (Surgery, Peripheral Intervention, Urology) | $4,300 | $4,000 | +7.5% |
| Total Revenue | $20,200 | $19,400 | +4.1% |
BD Medical (Medication Delivery, Medication Management, Pharm Systems) — 50% of Revenue
BD Life Sciences (Biosciences, Diagnostics) — 29% of Revenue
BD Interventional (Surgery, Peripheral Intervention, Urology) — 21% of Revenue
Income Statement Overview
| Metric | 2024 | 2023 |
|---|---|---|
| Total Revenue | $20,200 | $19,400 |
| Cost of Revenue | $10,300 | $10,000 |
| Gross Profit | $9,900 | $9,400 |
| Operating Expenses | $6,100 | $5,900 |
| Operating Income | $3,800 | $3,500 |
| Net Income | $2,200 | $1,600 |
All values in millions USD unless otherwise stated.
Key Financial Metrics
- Gross Margin: 49.0%
- Operating Margin: 18.8%
- Revenue Growth: 4.1%
Is Becton Dickinson Profitable?
Yes, Becton Dickinson is profitable. The company reported net income of $2,200 on total revenue of $20,200. With an operating margin of 18.8%, Becton Dickinson demonstrates solid profitability for the medical devices sector. The gross margin of 49.0% reflects Becton Dickinson’s pricing power and cost structure.
What to Watch
- Planned spinoff of Biosciences segment and remaining company focus
- BD Alaris infusion pump system remediation and FDA clearance progress
- Innovation pipeline in smart connected care and pharmacy automation
- Margin expansion from BD Excellence operational improvement program
Becton Dickinson (BDX) Financial Summary
Becton Dickinson (BDX) is a medical devices company that generated $20,200 in total revenue in fiscal year 2024. Revenue grew 4.1% year-over-year. The company earned $2,200 in net income, making it profitable. For a deeper look at Becton Dickinson’s revenue breakdown, business segments, and financial performance, review the detailed analysis above.